Infectious Diseases (all articles) | Page 165 of 298 | Links Medicus Content Curation & Alerts in Medicine

Study shows preexisting cross-reactive antibodies against common cold coronaviruses may protect against SARS-CoV-2 and are more common in children

9 Nov, 2020 | 01:28h | UTC

Preexisting and de novo humoral immunity to SARS-CoV-2 in humans – Science

Commentaries: Pre-existing coronavirus antibodies could help protect children against new pandemic strain – Francis Crick Institute AND Expert reaction to study looking at pre-existing coronavirus antibodies – Science Media Centre

Commentary on Twitter

Do some people have cross-reactive antibodies to #SARSCoV2? If so, who are they? And are these cross-reactive Abs protective against #COVID19? A fascinating study by @KevinWNg et al provides answers. Thread. (1/n)
https://t.co/U9UVrwztX5

— Prof. Akiko Iwasaki (@VirusesImmunity) November 7, 2020

New systematic review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 infection summarizes the clinical features, management, and outcomes of the disease, showing favorable outcomes for the majority of children

9 Nov, 2020 | 01:25h | UTC

A Systematic Review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection – The Pediatric Infectious Disease Journal

[Preprint] Research finds detectable but low-level SARS-CoV-2 contamination on public surfaces

6 Nov, 2020 | 09:56h | UTC

Research finds detectable but low-level SARS-CoV-2 contamination on public surfaces – News Medical

Original study (preprint): Longitudinal monitoring of SARS-CoV-2 RNA on high-touch surfaces in a community setting – medRxiv

Commentary on Twitter

Can you get COVID-19 from touching the grocery store door handle? Probably not – we estimate the risk at <5 in 10,000. But SARS-CoV-2 RNA on high-touch public surfaces may be a leading indicator of community case trends. New pre-print out! #1440funded https://t.co/x0IpYAlRuY

— Amy Pickering (@SeqH2O) November 2, 2020

Why scientists fear the “toxic” Covid-19 debate

6 Nov, 2020 | 09:57h | UTC

Why scientists fear the “toxic” Covid-19 debate – NewStatesman

UNICEF and WHO call for emergency action to avert major measles and polio epidemics

9 Nov, 2020 | 01:15h | UTC

UNICEF and WHO call for emergency action to avert major measles and polio epidemics – World Health Organization

Commentary: UN urges resumption of mass measles and polio vaccinations – The Guardian

Perspective: Rich countries reserve billions of Covid-19 vaccine doses even before there is one

6 Nov, 2020 | 09:52h | UTC

Rich Countries Reserve Billions Of Covid-19 Vaccine Doses Even Before There Is One – Forbes

Clots, strokes and rashes. Is COVID-19 a disease of the blood vessels?

6 Nov, 2020 | 09:54h | UTC

Clots, Strokes And Rashes. Is COVID-19 A Disease Of The Blood Vessels? – NPR

[Abstract Only] New clinical prediction rule for distinguishing bacterial from aseptic meningitis in children

6 Nov, 2020 | 09:32h | UTC

Clinical Prediction Rule for Distinguishing Bacterial From Aseptic Meningitis – Pediatrics (link to abstract – $ for full-text)

Commentary: How to Tell Bacterial vs Viral Meningitis – Journal Feed

Commentary on Twitter

The MSE (Meningitis Score for Emergencies): a tool that distinguishes aseptic from bacterial meningitis in children aged 1 month to 14 years. An impressive collaborative work of @TSEUP . #AlDiaSEUP @MintegiSanti @JavierBenitoF https://t.co/r6QHjUka88

— riseup-sperg (@riseup_sperg) August 25, 2020

High prevalence of pericardial involvement in college student-athletes recovering from COVID-19

5 Nov, 2020 | 09:08h | UTC

High Prevalence of Pericardial Involvement in College Student-Athletes Recovering From COVID-19 – JACC: Cardiovascular Imaging

Commentary on Twitter

The heart and #COVID19 in 54 consecutive college athletes @WVUHealth w/ echo, MRIhttps://t.co/76DvMNaeBL @JACCJournals todayhttps://t.co/hMyY8cQNln @ppsengupta1 @BritoCardio
>1/3 had resolving pericarditis with mild-moderate covid or no symptoms; no myocarditis, no controls pic.twitter.com/GTj3JZxL26

— Eric Topol (@EricTopol) November 5, 2020

Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination. Efficacy, duration of protection, and percentage of the population receiving the vaccine are key issues

5 Nov, 2020 | 09:09h | UTC

Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination – The Lancet

Commentary on Twitter

The real deal herd immunity, via a #SARSCoV2 vaccine, will be a formidable feat to achieve, with efficacy, coverage levels and duration of protection as key determinants https://t.co/3jeXkO5Yak @TheLancet pic.twitter.com/mXcDpHbHR6

— Eric Topol (@EricTopol) November 5, 2020

Opinion: Disagree on Covid-19, but don’t demonize other views

5 Nov, 2020 | 09:04h | UTC

Disagree on Covid-19, but don’t demonise other views – Research Professional News

Postmortem lungs of COVID-19 patients show massive damage

5 Nov, 2020 | 09:06h | UTC

Postmortem lungs of COVID-19 patients show massive damage- CIDRAP

Original article: Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology – EBioMedicine

NICE Guideline: Human and animal bites. Assessment, indications for antibiotic prophylaxis in uninfected bites, and choice of antibiotic are reviewed

5 Nov, 2020 | 09:02h | UTC

Human and animal bites: antimicrobial prescribing – National Institute for Health and Care Excellence

The neurological sequelae of pandemics and epidemics. A review of large and important epidemics of human history in which neurological manifestations are evident

5 Nov, 2020 | 08:51h | UTC

The neurological sequelae of pandemics and epidemics – Journal of Neurology

SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts

4 Nov, 2020 | 09:51h | UTC

SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study – The Lancet Infectious Diseases

Commentary on Twitter

Important new study on #SARSCoV2 transmission of >1,100 cases with 7,700 close contacts
— 36% asymptomatic; require testing
— Household contact risk: sharing bedroom >5X; speaking w/ 1° case for ≥ 30 min: 7.9Xhttps://t.co/lSKebOzoNf @TheLancetInfDis pic.twitter.com/UTtkCUqlRn

— Eric Topol (@EricTopol) November 3, 2020

Study: Strategies to prevent super-spreading events could have a significant impact on the overall transmission of Covid-19

4 Nov, 2020 | 09:56h | UTC

Covid-19 “super-spreading” events play outsized role in overall disease transmission – Massachusetts Institute of Technology (MIT)

Original study: Evidence that coronavirus superspreading is fat-tailed – Proceedings of the National Academy of Sciences

New CDC Report found that pregnant women with Covid-19 are more likely to have severe illness

4 Nov, 2020 | 09:47h | UTC

Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020 – CDC Morbidity and Mortality Weekly Report

Commentary: Pregnant women with Covid-19 face higher risk of severe illness and death, study says – CNN

Key populations for early COVID-19 immunization: Preliminary guidance for policy

4 Nov, 2020 | 09:46h | UTC

Key populations for early COVID-19 immunization: preliminary guidance for policy – Canadian Medical Association Journal

Commentary on Twitter

Preliminary guidance on key populations for early #COVID19 immunization: groups include those at high risk for severe illness and death, essential workers, #Indigenous communities. Read the evidence-based guideline https://t.co/Tc3vBdJxSV @CPHO_Canada @GovCanHealth @CaroQuach pic.twitter.com/3vyGkL87AD

— CMAJ (@CMAJ) November 3, 2020

The double threat of COVID-19 in Africa

4 Nov, 2020 | 09:43h | UTC

The Double Threat of COVID-19 in Africa – Think Global Health

Updated clinical guide for the critical care management of adults with COVID-19

3 Nov, 2020 | 03:18h | UTC

Clinical guide for the management of critical care for adults with COVID-19 during the Coronavirus pandemic – Intensive Care Society

Age-specific mortality and immunity patterns of SARS-CoV-2

3 Nov, 2020 | 03:16h | UTC

Age-specific mortality and immunity patterns of SARS-CoV-2 – Nature

Commentary: Focus on COVID-19 deaths in under-65s for better insights into infection rates across populations, say researchers – University of Cambridge

Commentaries on Twitter

Our analysis on age-specific mortality and immunity patterns of SARS-CoV-2 has now been published @nature. We look at COVID-19 death data in 45 countries and 22 serostudies to investigate the consistency of infection & fatality patterns across countries https://t.co/KLYR7XrFo8

— Megan O'Driscoll (@meganodris) November 2, 2020

The effect of age on the #COVID19 infection fatality rate. Just published @nature, data from 45 countries, 22 seroprevalence studies https://t.co/TWSogoHMMh
by @meganodris @hsalje @SCauchemez @fdlwang @datcummings @andrewazman and colleagues pic.twitter.com/pXtvZky4xA

— Eric Topol (@EricTopol) November 2, 2020

Analysis: Harms of public health interventions against covid-19 must not be ignored

3 Nov, 2020 | 03:14h | UTC

Harms of public health interventions against covid-19 must not be ignored – The BMJ

Commentary on Twitter

The harmful consequences of public health choices to limit the spread of covid-19 should be explicitly considered and transparently reported to limit their damage, say Itai Bavli and colleagues https://t.co/i83wFx7RBk

— The BMJ (@bmj_latest) November 2, 2020